|Adaptive Healthcare Fund||California, Los Angeles, United States|
|Aioi Nissay Dowa Insurance Co., Ltd||-|
|Biohaven Pharmaceutical||Connecticut, New Haven, United States|
|China Create Capital Limited||China, Guangdong, Shenzhen|
|FA Technology Ventures||Massachusetts, United States, Waltham|
|Mendoza Ventures||Boston, Massachusetts, United States|
|Mingly Capital Corporation||China, Hong Kong, Hong Kong Island|
|Morgenthau Venture Partners||Florida, Fort Lauderdale, United States|
|New England Partners||Massachusetts, Quincy, United States|
|Sagin Capital & Consulting||Japan, Saga, Saga Prefecture|
|Subversive Capital||New York, New York, United States|
|Sway Ventures||California, San Francisco, United States|
|Thin Air Labs||Alberta, Calgary, Canada|
|Twin Ventures||California, San Francisco, United States|
|Venvest Capital||California, Santa Monica, United States|
|WEH Ventures||India, Maharashtra, Mumbai|
|$23M||21 Mar 2022||Calgary, Canada|
|$1M||17 Mar 2022||Edmonton, Canada|
|$10M||10 Nov 2021||Calgary, Canada|
|$2M||27 Oct 2021||Seattle, Washington, United States|
|$650K||22 Sep 2021||Montréal, Quebec, Canada|
|$3M||19 Feb 2021||New York, New York, United States|
|$620K||01 Nov 2020||Calgary, Canada|
|$6M||08 Sep 2020||Calgary, Canada|
|15 Jul 2020||Edmonton, Canada|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.